Indication
Anaplastic Glioma
1 clinical trial
1 product
Clinical trial
Phase II Clinical Trial of HSV G207 With a Single 5 Gy Radiation Dose in Children With Recurrent High-Grade GliomaStatus: Not yet recruiting, Estimated PCD: 2028-12-02
Product
Biological G207